Publication date: Available online 23 October 2026 Source: Annals of Oncology Author(s): K. Fizazi, N.W. Clarke, M. De Santis, H. Uemura, A.P. Fay, N. Karadurmus, C. Alvarez-Fernandez, S. Jiang, D. Parslow, M. Sotelo, Y. Ürün, N. Oliveira, T. Gyun Kwon, M. Özgüroğlu, G. Roubaud, D. Castellano, J.K. Logan, T. Morris, C. Gresty, D.J. George
Capivasertib plus abiraterone in PTEN-deficient de novo metastatic hormone-sensitive prostate cancer: updated survival analysis from CAPItello-281☆. // Annals of Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S092375342606878X?dgcid=rss_sd_all
Capivasertib plus abiraterone in PTEN-deficient de novo metastatic hormone-sensitive prostate cancer: updated survival analysis from CAPItello-281☆. Annals of Oncology. https://www.sciencedirect.com/science/article/pii/S092375342606878X?dgcid=rss_sd_all
“Capivasertib plus abiraterone in PTEN-deficient de novo metastatic hormone-sensitive prostate cancer: updated survival analysis from CAPItello-281☆.” Annals of Oncology.
@article{article36287,
title = {Capivasertib plus abiraterone in PTEN-deficient de novo metastatic hormone-sensitive prostate cancer: updated survival analysis from CAPItello-281☆},
journal = {Annals of Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S092375342606878X?dgcid=rss_sd_all}
}
ABSTRACT Diagnosing and classifying platelet disorders (PD) is challenging in children. Therefore, we evaluated clinical, laboratory, and genetic data to improve current algorithms by performing a prospective observational cohort study...
Abstract Background and Objectives Perioperative blood transfusion in hip arthroplasty is associated with increased morbidity, prolonged hospitalization, and higher costs. This study aimed to identify independent risk factors and...